Radiation
fractionated radiotherapy
fractionated radiotherapy is a radiation therapy with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
RADIATION
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
completed133%
terminated133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_1
Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
NCT05737368
completedphase_4
Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)
NCT01553032
terminatednot_applicable
Stereotactic Radiosurgery in Metastatic Spinal Cord Compression
NCT02167633
Clinical Trials (3)
Showing 3 of 3 trials
NCT05737368Phase 1
Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
NCT01553032Phase 4
Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)
NCT02167633Not Applicable
Stereotactic Radiosurgery in Metastatic Spinal Cord Compression
All 3 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 3